Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)

NCT05569954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1484

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: V116
BIOLOGICAL: PPSV23

Sponsor

Merck Sharp & Dohme LLC